18 results
424B5
ZYME
Zymeworks Inc.
3 May 24
Prospectus supplement for primary offering
4:17pm
enrollment is planned;
inability to obtain sufficient funds required for a clinical trial;
inability to recruit clinical operations personnel and other … ability to recruit any necessary preclinical research, clinical, regulatory and other professional staff on the timeframe required to support our research
424B5
ZYME
Zymeworks Inc.
3 May 24
Prospectus supplement for primary offering
4:11pm
for a clinical trial;
inability to recruit clinical operations personnel and other personnel with later-stage development experience;
clinical holds … may receive; and
S-39
limitations on our ability to recruit any necessary preclinical research, clinical, regulatory and other professional staff
8-K
EX-99.1
7h678vja0oqk25 1sy
7 Nov 23
Zymeworks Provides Corporate Update and Reports Third Quarter 2023 Financial Results
4:08pm
424B5
q73mgjvujamz05 9vt
8 May 23
Prospectus supplement for primary offering
5:19pm
424B5
1atp60zbtd shy
8 May 23
Prospectus supplement for primary offering
5:18pm
424B5
l1wh6iz
9 Nov 22
Prospectus supplement for primary offering
4:29pm
10-Q
qc6svlxul8jo
8 Nov 22
Quarterly report
4:09pm
424B5
jndoayi 56bftzyytinr
21 Oct 22
Prospectus supplement for primary offering
4:16pm
424B5
nvr80n3p6 5wo3d
13 Oct 22
Prospectus supplement for primary offering
4:56pm
425
zuoki owroz1o
15 Jul 22
Business combination disclosure
5:26pm
425
0zra6t
15 Jul 22
Business combination disclosure
5:12pm
- Prev
- 1
- Next